Form 4: INSMED Chief Medical Officer Sells Shares to Cover Tax Obligations

INSMED Inc.'s Chief Medical Officer, Dr. Martina Flammer, sold 1,686 shares of common stock at $71.50 per share on June 3, 2025, to satisfy tax withholding obligations and cover related broker fees.

Summary

• Dr. Martina Flammer, Chief Medical Officer and Director of INSMED Inc., reported a transaction involving the company's common stock.
• On June 3, 2025, Dr. Flammer disposed of 1,686 shares of INSMED common stock.
• The shares were sold at a price of $71.50 per share, totaling approximately $120,579.
• The purpose of the sale was to satisfy tax withholding obligations arising from the vesting of Restricted Stock Units (RSUs) and to cover associated broker fees.
• Following this transaction, Dr. Flammer beneficially owns 83,111 shares of INSMED common stock directly.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged sale.

Sentiment

Score: 5

Explanation: The transaction is a routine sale of shares to cover tax obligations upon RSU vesting, which is a common and expected event for executives. It does not indicate a change in sentiment towards the company's prospects.

Industry Context

This Form 4 filing details a routine insider stock transaction for tax purposes, which is common across all industries, particularly for executives receiving equity compensation like Restricted Stock Units. It does not provide insights into broader industry trends or competitive dynamics within the biotechnology or pharmaceutical sector where INSMED operates.

Stakeholder Impact

• The transaction has minimal direct impact on shareholders as it represents a routine, pre-planned sale for tax purposes by an executive, not a discretionary sale indicating a lack of confidence. Employees and customers are not directly impacted by this specific filing.

Key Dates

Keywords

INSMED Inc., INSM, Form 4, Insider Trading, Stock Sale, Chief Medical Officer, Martina Flammer, Restricted Stock Units, Tax Withholding, Rule 10b5-1